ENGAGE XR Holdings (EXR), a metaverse technology company, announce that, further to the announcement made on 28 September 2022, Lenovo™â€™s new ThinkReality™ VRX all-in-one virtual reality (VR) headset engineered for
ENGAGE XR Holdings (EXR), a metaverse technology company, announce that, further to the announcement made on 28 September 2022, Lenovo™â€™s new ThinkReality™ VRX all-in-one virtual reality (VR) headset engineered for
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Abingdon, Cleantech, Chaarat, Eurasia,
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Arrow, Bushveld, Baron,
Horizonte Minerals (HZM) announced that it has entered into a five-year mining services agreement, thereby securing services for mining, stockpile generation, plant feeding and slag handling activities for its 100%-owned
Hurry while stocks last could be the description at ValiRx (VAL), a life science company. It announced that it wishes to provide investors who did not participate in the Fundraising
Chaarat (CGH), the AIM-quoted gold mining company, announced the updated JORC Compliant Mineral Resource Estimate for its Kapan polymetallic mine in the Republic of Armenia.
Greatland Gold (GGP), a mining development and exploration company, provided an exploration and development update at the Havieron gold-copper project in the Paterson region of Western Australia.
The newsflow appears to be accelerating at Chaarat Gold (CGH), the AIM-quoted gold mining company with an operating mine in Armenia, and assets at various stages of development in the
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound / Dollar, Bitcoin,
Poolbeg Pharma (POLB), a clinical stage infectious disease pharmaceutical company, announced that Chief Executive Officer, Jeremy Skillington, has purchased 718,733 shares at 4.78p.